228 related articles for article (PubMed ID: 19715525)
1. Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.
Yosry A; Abdel-Rahman M; Esmat G; El-Serafy M; Omar A; Doss W; Zayed N; Said M; Ismail T; Hosny A; Marawan E; El-Malt O; Kamel RR; Hatata Y; El-Taweel A; Ghali A; Sabri H; Kamel S; El-Gabaly H
Exp Clin Transplant; 2009 Sep; 7(3):157-63. PubMed ID: 19715525
[TBL] [Abstract][Full Text] [Related]
2. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
[TBL] [Abstract][Full Text] [Related]
3. Rapid fibrosis and significant histologic recurrence of hepatitis C after liver transplant is associated with higher tumor recurrence rates in hepatocellular carcinomas associated with hepatitis C virus-related liver disease: a single center retrospective analysis.
Vasavada BB; Chan CL
Exp Clin Transplant; 2015 Feb; 13(1):46-50. PubMed ID: 25654412
[TBL] [Abstract][Full Text] [Related]
4. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
[TBL] [Abstract][Full Text] [Related]
5. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
[TBL] [Abstract][Full Text] [Related]
6. Recurrent hepatitis C virus infection and outcome after living-donor liver transplant.
Satapathy SK; Fiel MI; Vanatta JM; Del Rio Martin J; Schiano TD
Exp Clin Transplant; 2013 Dec; 11(6):522-9. PubMed ID: 23901801
[TBL] [Abstract][Full Text] [Related]
7. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
8. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
[TBL] [Abstract][Full Text] [Related]
9. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B.
Bzowej N; Han S; Degertekin B; Keeffe EB; Emre S; Brown R; Reddy R; Lok AS;
Liver Transpl; 2009 Sep; 15(9):1010-20. PubMed ID: 19718627
[TBL] [Abstract][Full Text] [Related]
12. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
[TBL] [Abstract][Full Text] [Related]
13. Serial measurements of hepatitis C viral load by real-time polymerase chain reaction among recipients of living-donor renal transplants: a short-term follow-up study from a single center.
Justa S; Minz RW; Minz M; Sharma A; Anand S; Das A; Chawla YK; Sakhuja VK
Transplant Proc; 2010 Nov; 42(9):3568-73. PubMed ID: 21094817
[TBL] [Abstract][Full Text] [Related]
14. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
15. Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.
Lim KB; Sima HR; Fiel MI; Khaitova V; Doucette JT; Chernyiak M; Ahmad J; Bach N; Chang C; Grewal P; Kim-Schluger L; Liu L; Odin J; Perumalswami P; Florman SS; Schiano TD
World J Gastroenterol; 2015 May; 21(20):6236-45. PubMed ID: 26034358
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
[TBL] [Abstract][Full Text] [Related]
17. Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus.
Ju W; Chen M; Guo Z; Wang D; Zhu X; Huang J; He X
Exp Clin Transplant; 2013 Jun; 11(3):245-9. PubMed ID: 23176583
[TBL] [Abstract][Full Text] [Related]
18. The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma.
Lu D; Yang F; Zhuo J; Yang M; Lin Z; Jin P; Cai X; Cen B; Wang J; Wei X; Zheng S; Xu X
Clin Transl Gastroenterol; 2020 May; 11(5):e00168. PubMed ID: 32358239
[TBL] [Abstract][Full Text] [Related]
19. Living donor liver transplantation for hepatitis C.
Takada Y; Uemoto S
Surg Today; 2013 Jul; 43(7):709-14. PubMed ID: 23052749
[TBL] [Abstract][Full Text] [Related]
20. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
